INSIGHTS ON CLINICAL TRIAL TECHNOLOGIES

• Citeline SmartSolutions

  Citeline SmartSolutions is a new generation of AI-powered clinical solutions including tools to recommend primary endpoints and inclusion/exclusion criteria and instantly generate a list of protocol-matched investigators for your trial.

• Connected Data For Mission-Critical, Time-Sensitive Moments In A Clinical Trial

  Embrace the power of a unified eCOA and IRT platform to drive smarter decisions, ensure data accuracy, and boost efficiency across your studies.

• Avoid Database Go-Live Delays With The Right EDC System

  If you are looking to speed up your start-up process, selecting a reliable EDC System is key.

• Clinical Trial Matching With AI And Large Language Models

  Unlock more accurate clinical trial matching by using AI to interpret complex patient notes, reducing the manual screening burden and identifying eligible candidates with higher precision.

• Reinventing Prostate Cancer Diagnostics With An All-In-One Platform

  3/31/2026

  Discover how a lean research team saved an estimated $100k and reached 95% data compliance by unifying their clinical workflow.

• The Problem With Adding RTSM Software Into An eClinical Suite

  5/13/2026

  RTSM software is very different from other eClinical tools, and trying to bundle it into an all-in-one platform can sometimes create more challenges than advantages.

• How EDC Software Improves Patient Safety

  3/10/2025

  As clinical research evolves, EDC remains a cornerstone for data accuracy, ethical compliance, and faster access to effective treatments.

• Different Stakeholder Perspectives On Navigating DHT Guidance

  11/21/2024

  In a recent panel, industry leaders discussed the implications of FDA guidance for sponsors and developers implementing DHT as an innovative way to capture multidimensional patient data remotely.

• Policy To Practice: PBM Reform, TrumpRx, And Global Drug Development

  3/4/2026

  Policy shifts are reshaping PBM oversight, driving transparent drug‑pricing tools, and influencing global responses that affect affordability, access, and future pharma development.